Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole Oral Solution in Children and Adolescents With Tourette's Syndrome
NCT03487783Phase 3Completed
- Sponsor
- Otsuka Holdings
- Start
- May 2018
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aripiprazole in Tourette syndrome (TS), sponsored by Otsuka Holdings. Started May 2018; status: completed.
02
Drugs
aripiprazole
03
Conditions
Tourette syndrome (TS)
Beyond the preview
Go deeper on NCT03487783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03487783.